HIGHLIGHTS
- who: Song Li from the (UNIVERSITY) have published the research work: Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer, in the Journal: (JOURNAL) of 11/03/2022
- what: In this single-armed, phase II, exploratory trial (NCT03878472), the authors evaluate the efficacy of a combination of ICI (camrelizumab), antiangiogenesis (apatinib), and chemotherapy (S-1 u00b1 oxaliplatin) for neoadjuvant/conversion treatment of cT4a/bN+ gastric cancer.
- how: By contrast the preliminary data showed that apatinib did not show high-incidence morbidities including anastomotic leakage (5%) and wound healing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.